X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1752) 1752
Book Review (290) 290
Publication (166) 166
Newsletter (133) 133
Book Chapter (19) 19
Conference Proceeding (19) 19
Newspaper Article (11) 11
Magazine Article (5) 5
Dissertation (2) 2
Presentation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
abacavir (1399) 1399
index medicus (1101) 1101
humans (1017) 1017
hiv infections - drug therapy (649) 649
infectious diseases (619) 619
hiv (580) 580
male (530) 530
female (506) 506
adult (438) 438
immunology (410) 410
lamivudine (385) 385
pharmacology & pharmacy (381) 381
antiretroviral therapy (370) 370
antiviral agents (352) 352
middle aged (349) 349
anti-hiv agents - therapeutic use (332) 332
anti-hiv agents - adverse effects (316) 316
tenofovir (313) 313
drug therapy (275) 275
human immunodeficiency virus--hiv (265) 265
virology (259) 259
hiv infection (252) 252
dideoxynucleosides - adverse effects (239) 239
antiretroviral drugs (236) 236
zidovudine (232) 232
aids/hiv (231) 231
dideoxynucleosides - therapeutic use (227) 227
research (210) 210
efavirenz (204) 204
hypersensitivity (203) 203
risk factors (201) 201
pharmacogenetics (191) 191
highly active antiretroviral therapy (180) 180
therapy (179) 179
emtricitabine (173) 173
drug therapy, combination (170) 170
anti-hiv agents - administration & dosage (169) 169
drugs (169) 169
protease inhibitors (167) 167
hiv infections - virology (166) 166
treatment outcome (162) 162
health aspects (156) 156
viral load (154) 154
abacavir-lamivudine (153) 153
reverse transcriptase inhibitors - therapeutic use (153) 153
hiv-infected patients (150) 150
microbiology (146) 146
hiv patients (143) 143
aids (140) 140
abacavir hypersensitivity (139) 139
cd4 lymphocyte count (138) 138
hiv-1 (138) 138
hiv-1 - drug effects (137) 137
dideoxynucleosides - administration & dosage (134) 134
lamivudine - therapeutic use (134) 134
analysis (133) 133
dosage and administration (127) 127
complications and side effects (125) 125
human immunodeficiency virus (125) 125
clinical trials (121) 121
association (118) 118
hiv infections - complications (117) 117
adenine - analogs & derivatives (116) 116
care and treatment (114) 114
reverse transcriptase inhibitors - adverse effects (114) 114
nevirapine (113) 113
adults (110) 110
stavudine (109) 109
drug combinations (108) 108
medical research (108) 108
reverse-transcriptase inhibitors (108) 108
safety (107) 107
aged (106) 106
hla-b-asterisk-5701 (105) 105
genotype (104) 104
antiretroviral agents (101) 101
medicine & public health (101) 101
hiv-1 - genetics (100) 100
hla-b antigens - genetics (98) 98
histocompatibility antigens (96) 96
abridged index medicus (95) 95
hla histocompatibility antigens (95) 95
allergy (94) 94
hiv-1-infected patients (94) 94
acquired immune deficiency syndrome--aids (93) 93
hiv infections - immunology (93) 93
adolescent (92) 92
antiretroviral therapy, highly active (92) 92
pharmacokinetics (91) 91
drug hypersensitivity - genetics (89) 89
human-immunodeficiency-virus (88) 88
lamivudine - administration & dosage (87) 87
medicine, experimental (87) 87
risk (86) 86
medicine, general & internal (85) 85
active antiretroviral therapy (84) 84
efficacy (84) 84
article (83) 83
medicine (83) 83
rna, viral - blood (83) 83
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1848) 1848
Spanish (37) 37
French (18) 18
German (8) 8
Italian (2) 2
Korean (2) 2
Turkish (2) 2
Chinese (1) 1
Croatian (1) 1
Czech (1) 1
Hungarian (1) 1
Japanese (1) 1
Persian (1) 1
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


AIDS, ISSN 0269-9370, 06/2018, Volume 32, Issue 10, pp. 1387 - 1388
Journal Article
BMC medicine, ISSN 1741-7015, 2016, Volume 14, Issue 1, pp. 61 - 61
Journal Article
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, ISSN 1525-4135, 06/2017, Volume 75, Issue 2, pp. 226 - 231
In a double-blind, phase 3 trial, 663 HIV-infected, virologically suppressed adults were randomized to switch to tenofovir alafenamide (TAF; n = 333) vs.... 
osteopenia | ANTIRETROVIRAL-NAIVE | INFECTIOUS DISEASES | ABACAVIR-LAMIVUDINE | ELVITEGRAVIR | proteinuria | COBICISTAT | EMTRICITABINE | IMMUNOLOGY | DENSITY | HIV | EFAVIRENZ | DOUBLE-BLIND | ABACAVIR/LAMIVUDINE | tenofovir alafenamide | TENOFOVIR/EMTRICITABINE
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 2015, Volume 70, Issue 5, pp. 515 - 519
The SINGLE study was a randomized, double-blind, noninferiority study that evaluated the safety and efficacy of 50 mg dolutegravir + abacavir/lamivudine versus... 
Lamivudine | HIV | Abacavir | Dolutegravir | INFECTIOUS DISEASES | ONCE-DAILY DOLUTEGRAVIR | RALTEGRAVIR | ADULTS | abacavir | dolutegravir | IMMUNOLOGY | lamivudine
Journal Article
PloS one, ISSN 1932-6203, 2016, Volume 11, Issue 7, pp. e0159286 - e0159286
[This corrects the article DOI: 10.1371/journal.pone.0155406.]. 
Tenofovir | Emtricitabine | Lamivudine | Abacavir
Journal Article
AIDS, ISSN 0269-9370, 11/2015, Volume 29, Issue 18, pp. 2459 - 2464
Objective:Antiretroviral therapy initiation has been linked to bone mineral density and bone biomarker changes. We assessed long-term bone turnover biomarker... 
POPULATION | INFECTIOUS DISEASES | ABACAVIR-LAMIVUDINE | RALTEGRAVIR | tenofovir | EMTRICITABINE | dolutegravir | IMMUNOLOGY | OSTEOPOROSIS | HIV-INFECTED PATIENTS | MINERAL DENSITY | VIROLOGY | bone markers | osteocalcin | FRACTURES | abacavir | TENOFOVIR/EMTRICITABINE | efavirenz
Journal Article
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, ISSN 1413-8670, 07/2019
Abacavir can cause a multi-systemic hypersensitivity reaction (HSR) in 5-8% of the patients, which is related to HLA-B*57-01 allele. In Brazil, the HLA-B*57-01... 
Index Medicus
Journal Article
Infection and Drug Resistance, ISSN 1178-6973, 2019, Volume 12, pp. 1385 - 1391
Metabolic disorders are common amongst HIV-infected patients. Data from real-life setting on the impact of DTG/ABC/3TC in virologically suppressed HIV-infected... 
HIV-1 infection | Lipid profile | Dolutegravir/abacavir/lamivudine | dolutegravir/abacavir/lamivudine | lipid profile
Journal Article
Journal Article
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 09/2010, Volume 55, Issue 1, pp. 49 - 57
Background: Abacavir/lamivudine and tenofovir/emtricitabine fixed-dose combinations are commonly used first-line antiretroviral therapies, yet few studies have... 
HIV-1 | Efficacy | Abacavir/lamivudine | Tenofovir/emtricitabine | Cardiovascular | Renal | ABACAVIR | tenofovir/emtricitabine | INFECTIOUS DISEASES | MYOCARDIAL-INFARCTION | CARDIOVASCULAR EVENTS | THYMIDINE ANALOG | TENOFOVIR DF | RISK | IMMUNOLOGY | cardiovascular | efficacy | abacavir/lamivudine | HIV-INFECTED PATIENTS | renal | REVERSE-TRANSCRIPTASE INHIBITORS | THERAPY | CHRONIC KIDNEY-DISEASE | Lamivudine - administration & dosage | Humans | Middle Aged | Male | Viral Load | Anti-HIV Agents - administration & dosage | Lamivudine - adverse effects | Tenofovir | Young Adult | Glomerular Filtration Rate - drug effects | Adenine - adverse effects | HIV-1 - isolation & purification | Adult | Deoxycytidine - adverse effects | Female | Dideoxynucleosides - adverse effects | Dideoxynucleosides - administration & dosage | Emtricitabine | Adenine - analogs & derivatives | Kidney - drug effects | Benzoxazines - administration & dosage | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | Organophosphonates - adverse effects | beta 2-Microglobulin - urine | Benzoxazines - adverse effects | Treatment Outcome | Retinol-Binding Proteins - urine | Adenine - administration & dosage | Organophosphonates - administration & dosage | Adolescent | HIV Infections - drug therapy | Aged | Deoxycytidine - analogs & derivatives | Drug Combinations | Proteins | Antiretroviral drugs | Human immunodeficiency virus--HIV | Clinical trials | Adults | Drug therapy | Binding sites | Effectiveness studies | Index Medicus | AIDS/HIV
Journal Article
HEPATOLOGY, ISSN 0270-9139, 02/2013, Volume 57, Issue 2, pp. 727 - 739
The role of the adaptive immune system in adverse drug reactions that target the liver has not been defined. For flucloxacillin, a delay in the reaction onset... 
ABACAVIR | IN-VITRO | HLA-A-ASTERISK-3101 | PEPTIDE REPERTOIRE | REACTIVITY | GENOME-WIDE | PIPERACILLIN | CYSTIC-FIBROSIS | GASTROENTEROLOGY & HEPATOLOGY | STEVENS-JOHNSON-SYNDROME | HYPERSENSITIVITY
Journal Article